×
Cryo-Cell EBITDA 2010-2025 | CCEL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Cryo-Cell ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
Cryo-Cell EBITDA 2010-2025 | CCEL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Cryo-Cell ebitda from 2010 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$147.7B
CVS Health (CVS)
$90.7B
Elevance Health (ELV)
$69.8B
Cencora (COR)
$56.2B
DiDi Global (DIDIY)
$27.9B
Labcorp Holdings (LH)
$23.1B
Natera (NTRA)
$22.7B
BioMerieux (BMXMF)
$17.4B
EUROFINS SCIENT (ERFSF)
$14.5B
ICON (ICLR)
$13.9B
Medpace Holdings (MEDP)
$13.2B
CochLear (CHEOY)
$12.9B
Solventum (SOLV)
$12.6B
Viatris (VTRS)
$12.1B
Caris Life Sciences,�Inc (CAI)
$10.8B
Revvity (RVTY)
$10.6B
Avantor (AVTR)
$9.1B
Charles River Laboratories (CRL)
$8.1B
Sonic Healthcare (SKHHY)
$7.7B
HealthEquity (HQY)
$7.7B
Bausch + Lomb (BLCO)
$5.1B
Sotera Health (SHC)
$4.7B
BrightSpring Health Services (BTSG)
$4.2B
Amplifon S.p.A (AMFPF)
$3.9B
GeneDx Holdings (WGS)
$3.6B
Alignment Healthcare (ALHC)
$3.1B
KindlyMD (NAKA)
$3B
Concentras Parent (CON)
$2.9B
Surgery Partners (SGRY)
$2.9B
Organon (OGN)
$2.4B